Human medicines European public assessment report (EPAR): Spinraza, nusinersen, Date of authorisation: 30/05/2017, Revision: 20, Status: Authorised

Human medicines European public assessment report (EPAR): Zubsolv, buprenorphine,naloxone, Date of authorisation: 10/11/2017, Revision: 14, Status: Authorised

Human medicines European public assessment report (EPAR): Remsima, infliximab, Date of authorisation: 10/09/2013, Revision: 45, Status: Authorised

Human medicines European public assessment report (EPAR): Firazyr, icatibant, Date of authorisation: 11/07/2008, Revision: 27, Status: Authorised

Eligible patients and consumers organisations

Human medicines European public assessment report (EPAR): INOmax, nitric oxide, Date of authorisation: 01/08/2001, Revision: 26, Status: Authorised

Human medicines European public assessment report (EPAR): Insulin lispro Sanofi, insulin lispro, Date of authorisation: 19/07/2017, Revision: 11, Status: Authorised

Human medicines European public assessment report (EPAR): Zykadia, ceritinib, Date of authorisation: 06/05/2015, Revision: 24, Status: Authorised

Human medicines European public assessment report (EPAR): Arixtra, fondaparinux sodium, Date of authorisation: 20/03/2002, Revision: 38, Status: Authorised

Veterinary medicines European public assessment report (EPAR): Varenzin, molidustat, Status: Authorised